What is the recommended initial dose of noradrenaline (norepinephrine) for an adult patient with shock, particularly those with a history of cardiovascular disease, trauma, or severe infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Norepinephrine Dosing in Shock

Start norepinephrine at 0.1-0.5 mcg/kg/min (approximately 0.5 mg/h or 8-12 mcg/min in a 70 kg adult) via continuous IV infusion, targeting a mean arterial pressure of 65 mmHg, with central venous access strongly preferred and concurrent fluid resuscitation of at least 30 mL/kg crystalloid. 1, 2, 3

Critical Pre-Administration Requirements

Administer a minimum 30 mL/kg crystalloid bolus before or concurrent with norepinephrine initiation—do not delay vasopressors while pursuing aggressive fluid resuscitation in severe hypotension (systolic <70 mmHg or diastolic ≤40 mmHg). 1, 2, 3 Vasoconstriction in hypovolemic patients causes severe organ hypoperfusion despite "normal" blood pressure numbers. 2, 3

In patients with profound, life-threatening hypotension (diastolic ≤40 mmHg or diastolic shock index ≥3), early norepinephrine administration simultaneously with fluid resuscitation should be prioritized, as duration and depth of hypotension strongly worsen outcomes. 4

Administration Route and Monitoring

  • Central venous access is strongly preferred to minimize extravasation risk and tissue necrosis. 1, 2, 5, 3 If central access is unavailable or delayed, peripheral IV or intraosseous administration can be used temporarily with strict monitoring. 5

  • Place an arterial catheter as soon as practical for continuous blood pressure monitoring in all patients requiring vasopressors. 2, 3

  • Monitor blood pressure and heart rate every 5-15 minutes during initial titration. 5, 3

Titration Protocol

  • Start at 0.1-0.5 mcg/kg/min (0.5 mg/h using standard concentration of 4 mg in 250 mL D5W = 16 mcg/mL). 5, 3

  • Increase by 0.5 mg/h every 4 hours as needed, up to a maximum of 3 mg/h. 5, 3

  • Target MAP ≥65 mmHg for most patients, though patients with chronic hypertension may require higher targets (70-75 mmHg). 1, 2, 3

  • Titrate to tissue perfusion markers beyond just MAP: lactate clearance ≥10%, urine output >50 mL/h for at least 4 hours, normalization of capillary refill, appropriate mental status, and age-appropriate heart rate. 1, 2, 3

Escalation Strategy for Refractory Hypotension

When norepinephrine reaches 0.25 mcg/kg/min (approximately 15-20 mcg/min) and hypotension persists, add vasopressin 0.03 units/min as second-line therapy rather than continuing to escalate norepinephrine alone. 1, 2, 3 Patients requiring ≥15 mcg/min of norepinephrine have significantly elevated mortality, and doses above 0.6 mcg/kg/min are associated with higher organ dysfunction scores and likely represent hypovolemia. 6, 7

  • Vasopressin 0.03 units/min can be added to raise MAP to target or decrease norepinephrine dosage, but should never be used as monotherapy. 1, 2, 3 Do not increase vasopressin above 0.03-0.04 units/min—reserve higher doses for salvage therapy only, as they are associated with cardiac, digital, and splanchnic ischemia. 1, 2

  • Epinephrine 0.05-2 mcg/kg/min may be added as a third agent when norepinephrine plus vasopressin fail to achieve target MAP. 1, 2, 3 However, epinephrine causes transient lactic acidosis through β2-adrenergic stimulation and increases myocardial oxygen consumption more than norepinephrine. 2

  • Dobutamine 2.5-20 mcg/kg/min should be added if persistent hypoperfusion exists despite adequate MAP and vasopressor therapy, particularly when myocardial dysfunction is evident. 1, 2, 3 Start at 2.5 mcg/kg/min and double every 15 minutes according to response, with dose titration usually limited by excessive tachycardia or arrhythmias. 2

Special Populations

Patients with Cardiovascular Disease

  • Norepinephrine may increase myocardial oxygen requirements, mandating cautious use in patients with ischemic heart disease, but this does not contraindicate its use. 2

  • Continue chronic beta-blockers in the absence of acute hemodynamic decompensation or cardiogenic shock; temporarily reduce or omit them if the patient is clinically unstable with signs of low cardiac output. 2

  • In sepsis specifically, norepinephrine improves renal blood flow and urine output despite typically causing renal vasoconstriction in other contexts. 2

Trauma Patients

  • High-dose norepinephrine (≥0.6 mcg/kg/min) in traumatic hemorrhagic shock is associated with higher organ dysfunction scores and likely represents inadequate volume resuscitation. 6

  • Ensure adequate non-blood resuscitation volume (≥9 mL/kg/h) to avoid the deleterious effects of excessive vasoconstriction in hypovolemic trauma patients. 6

Pregnant Patients

  • Start norepinephrine at 0.02 mcg/kg/min with a target MAP of 65 mmHg. 3

  • Consider more restrictive initial fluid boluses of 1-2 L due to lower colloid oncotic pressure and higher pulmonary edema risk. 3

Pediatric Patients

  • Start at 0.1 mcg/kg/min, titrating to desired clinical effect, with a typical range of 0.1-1.0 mcg/kg/min. 1, 5, 3

  • Maximum doses up to 5 mcg/kg/min may be necessary in some children, mandating central line placement. 1, 5

Critical Pitfalls to Avoid

Do not use dopamine as first-line therapy—it is associated with 11% higher absolute mortality and significantly more arrhythmias (53% risk reduction for supraventricular arrhythmias and 65% for ventricular arrhythmias with norepinephrine). 1, 2, 3 Dopamine should only be used in highly selected patients with absolute bradycardia and low risk of tachyarrhythmias. 1, 2

Do not use low-dose dopamine for "renal protection"—this is strongly discouraged and has no benefit. 1, 2, 3

Do not use phenylephrine as first-line therapy—it may raise blood pressure numbers while actually worsening tissue perfusion through excessive vasoconstriction. 1, 2, 3 Reserve phenylephrine only for specific circumstances: norepinephrine-induced serious arrhythmias, documented high cardiac output with persistent hypotension, or salvage therapy when all other agents have failed. 1, 2

Do not escalate norepinephrine beyond 0.6 mcg/kg/min without adding second-line agents—this likely represents inadequate volume resuscitation or irreversible circulatory failure. 6, 7 Scores >40 on APACHE II, bicarbonate <9.0 mEq/L, or epinephrine dose ≥0.25 mcg/kg/min are associated with 100% mortality. 7

Extravasation Management

If extravasation occurs, immediately infiltrate phentolamine 5-10 mg diluted in 10-15 mL of saline intradermally at the site to prevent tissue necrosis. 2, 5, 3 Pediatric dose: 0.1-0.2 mg/kg up to 10 mg. 5, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Vasopressor Management in Septic Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Noradrenaline Dosing for Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Norepinephrine Drip Administration Protocol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

High-dose norepinephrine treatment: determinants of mortality and futility in critically ill patients.

American journal of critical care : an official publication, American Association of Critical-Care Nurses, 2013

Related Questions

What is the recommended starting dose of noradrenaline (norepinephrine) for a patient with severe hypotension or septic shock?
What is the next step in management for a patient with acute kidney injury (AKI) and failure to thrive, who has already received fluid resuscitation with normal saline (NS) and lactated Ringer's (LR) solution, and is on midodrine, but still has hypotension with a mean arterial pressure (MAP) below 65?
What is the initial management and dosage of Adrenergic (ADr) receptor agonist infusion, specifically norepinephrine, for treating hypotension in septic shock?
What is the recommended dose of norepinephrine for an adult patient with septic shock or severe hypotension?
What is the recommended initial dose of noradrenaline (norepinephrine) in septic shock?
What is the cause of and how to manage itching on the palms and soles of a 23-year-old patient with no comorbidities, who recently swam in cold weather, had a fever, and did not respond to paracetamol and cetirizine?
What is the best course of treatment for a patient presenting with a hypersensitivity reaction and peri-orbital edema?
What is the recommended treatment and dosage of rabies immunoglobulin (RIG) for an individual exposed to rabies, possibly through an animal bite?
Can an adult patient without severe impaired renal function take cetirizine 10mg twice a day?
Would a topical corticosteroid (steroid cream) be sufficient for an adult patient with a skin condition possibly related to an allergic reaction and without severe renal impairment?
Does Advan (unknown medication) interact with metronidazole in a patient with Small Intestine Bacterial Overgrowth (SIBO)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.